초록 ▼

Antifibrinolytic agents (such as aprotinin) are not necessary because the tissue sealant contains high concentrations of natural inhibitors of fibrinolysis from the patient's blood. The tissue sealant also contains patient platelets and additional factors not present in available fibrin sealants tha

Antifibrinolytic agents (such as aprotinin) are not necessary because the tissue sealant contains high concentrations of natural inhibitors of fibrinolysis from the patient's blood. The tissue sealant also contains patient platelets and additional factors not present in available fibrin sealants that promote wound healing.

대표청구항 ▼

[ What is claimed as new and is desired to be secured by Letters Patent of the United States is:] [5.] A method for separating blood cells from a liquid suspension containing said blood cells and a liquid, comprising the steps of centrifuging said liquid suspension in a sealed container having a cen

[ What is claimed as new and is desired to be secured by Letters Patent of the United States is:] [5.] A method for separating blood cells from a liquid suspension containing said blood cells and a liquid, comprising the steps of centrifuging said liquid suspension in a sealed container having a central axis of rotation so that the liquid suspension moves radially outwardly from said axis of rotation and engages a mat, foam or porous plastic wall which bars passage of said blood cells in the absence of an applied centrifugal force but through which said blood cells pass in response to an applied centrifugal force and slowing said centrifuging of said liquid suspension so as to remove said liquid from said mat, foam or porous plastic wall whereby said blood cells remained trapped in said mat, foam or porous plastic wall after said centrifuging is slowed.